| Current price | $0.17 | 52-week high |
|---|---|---|
| Prev. close | $0.19 | 52-week low |
| Day low | $0.15 | Volume |
| Day high | $0.18 | Avg. volume |
| 50-day MA | $0.16 | Dividend yield |
Is gnpx stock having a great start to the New Year?
It’s safe to say that shareholders of GNPX stock are having a phenomenal start to the new year. Source: CI Photos / Shutterstock.com Today, the U.S. Food and Drug Administration (FDA) announced that it had granted fast track designation (FTD) for REQORSA, in combination with Merck’s
What was the earnings release for Aevi Genomic Medicine (GNMX)?
Aevi Genomic Medicine, LLC (NASDAQ:GNMX) announced its quarterly earnings data on Thursday, November, 1st. The biotechnology company reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.15) by $0.03.
Is Gentex Corporation (GNTX) stock about to trade ex-dividend?
Gentex Corporation ( NASDAQ:GNTX ) stock is about to trade ex-dividend in 4 days. The ex-dividend date is one business... The board of Gentex Corporation ( NASDAQ:GNTX ) has announced that it will pay a dividend of US$0.12 per share on the...
Will GNMX outperform or underperform the S&P 500 over the long term?
Vote “Outperform” if you believe GNMX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GNMX will underperform the S&P 500 over the long term. You may vote once every thirty days.
What happened GNMX CVR?
(GNMX) voted concerning the proposed merger with Cerecor Inc. (CERC). The merger was approved and subsequently consummated on February 3, 2020. As a result, each existing GNMX Common Share will be converted into the right to receive 0.0334 CERC Common Shares plus one non-transferable Contingent Value Right (“CVR”).
What is GNMX?
Aevi Genomic Medicine (GNMX)
What is NRF2 activator?
NRF2 (nuclear factor erythroid-2-related factor 2) is a transcription factor that activates over 500 genes via molecules called sirtuins. NRF2 activation can be achieved through exercise, calorie restriction (including fasting) and ingestion of natural nutrients that are NRF2 activators.
How were Aevi Genomic Medicine's earnings last quarter?
Aevi Genomic Medicine, LLC (NASDAQ:GNMX) released its quarterly earnings results on Thursday, November, 1st. The biotechnology company reported ($0...
Who are Aevi Genomic Medicine's key executives?
Aevi Genomic Medicine's management team includes the following people: Mr. Michael F. Cola , CEO, Pres & Director (Age 59) Mr. Brian D. Piper ,...
Who are some of Aevi Genomic Medicine's key competitors?
Some companies that are related to Aevi Genomic Medicine include Xtant Medical (XTNT) , Applied Genetic Technologies (AGTC) , Freeline Therapeut...
What other stocks do shareholders of Aevi Genomic Medicine own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Aevi Genomic Medicine investors own include Novavax (NVAX)...
What is Aevi Genomic Medicine's stock symbol?
Aevi Genomic Medicine trades on the NASDAQ under the ticker symbol "GNMX."
What is Aevi Genomic Medicine's stock price today?
One share of GNMX stock can currently be purchased for approximately $0.17.
How much money does Aevi Genomic Medicine make?
Aevi Genomic Medicine (NASDAQ:GNMX) has a market capitalization of $12.89 million. The biotechnology company earns $-30.77 million in net income (p...
How many employees does Aevi Genomic Medicine have?
Aevi Genomic Medicine employs 14 workers across the globe.
What is Aevi Genomic Medicine's official website?
The official website for Aevi Genomic Medicine is www.aevigenomics.com .
Component Grades
Aevi Genomic Medicine, Inc. (GNMX) Company Bio
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
Golden Star Signal
Aevi Genomic Medicine engages in the research and development of products in the field of biotechnology and associated medical equipment in the United States. It develops transduced autologous restorative gene therapy, TARGT platform to provide protein and peptide therapies to treat a range of chronic diseases and conditions.
Stock Podcast
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
